Over the last five years, large data sets on mortality in schizophrenia have been published
which have established mortality as a measurable clinical endpoint. Four issues need …

Background: It is generally believed that long-term use of antipsychotics increases mortality
and, especially, the risk of cardiovascular death. However, there are no solid data to …

Context Despite improvements in mental health services in recent decades, it is unclear
whether the risk of mortality in schizophrenia has changed over time. Objective To explore …

Compared to the general population, people with schizophrenia are at risk of dying
prematurely due to suicide and due to different somatic illnesses. The potential role of …

Schizophrenia is a life‐threatening disease associated with mortality rates that are two to
three times higher than those expected/observed in the general population. It is associated …

Purpose The purpose of this article is to describe the current status of knowledge on excess
mortality in schizophrenia and its causative factors, and to expand upon previous work …

Life expectancy and cardiovascular mortality in persons with... : Current Opinion in
Psychiatry Life expectancy and cardiovascular mortality in persons with schizophrenia …

BACKGROUND: Antipsychotic medication is the cornerstone of schizophrenia treatment.
The impact of long-term exposure to antipsychotics on life-expectancy has recently received …

People with schizophrenia die 15‐20 years prematurely. Understanding mortality risk and
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …

Patients with schizophrenia have a higher mortality risk than patients suffering from any
other psychiatric disorder. Previous research is inconclusive regarding the association of …